Medix Biochemica Organizational Update
Medix Biochemica organization has been updated to support the growth of the company. The company now consists of three business units:
• Immunodiagnostic Reagents
• IVD Biomaterials
• Diagnostic Tests
Each Business Unit is led by a Vice-President:
Laura-Leena Kiiskinen (Ph.D.) has been appointed Vice-President, Immunodiagnostic Reagents. She is based in Espoo, Finland, where we manufacture monoclonal antibodies and recombinant antigens used in IVD tests.
Matt Lee has been appointed Vice-President, IVD Biomaterials. The unit is providing native biomaterials and controls to the IVD manufacturers. Matt is based in St. Louis, MO, USA.
Sinikka Tiisala has been appointed Vice-President Diagnostic Tests. She is based in Espoo, Finland, where we develop Actim rapid tests for point of care use.
In addition to the Vice-Presidents of the Business Units, the following appointments have been made to Medix Biochemica Group Leadership Team:
Mariella Paroma, Vice-President, Human Resources;
Riitta Pelli, Chief Financial Officer;
Elina Carlson, Vice-President, Operations & Supply Chain;
Vincent Chen, Vice-President, Commercial Operations and GM, China;
Johanna Pesu, Group Leadership Team Assistant;
CEO Steve Ferguson is leading the Medix Biochemica Group Leadership Team.